F. F. Brinholi

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

M. Maes, C. Bortolasci, S. Nixdorf, 2016, Neuroscience Letters.

Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.

M. Maes, C. Bortolasci, E. Moreira, 2017, CNS & neurological disorders drug targets.

Increased oxidative stress in foam cells obtained from hemodialysis patients

C. Bortolasci, M. Watanabe, D. Barbosa, 2013, Hemodialysis international. International Symposium on Home Hemodialysis.

Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities

D. Barbosa, Michael Maes, F. F. Brinholi, 2022, Metabolic Brain Disease.

Increased lipid peroxidation and lowered lipid-associated antioxidant defenses mediate the effects of the paraoxonase 1 (PON1) Q192R polymorphism on disabilities and final stroke core volume in mild and moderate stroke.

D. Barbosa, Michael Maes, F. F. Brinholi, 2022, medRxiv.

Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.

R. Casagrande, E. Moreira, D. Barbosa, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

In Mild and Moderate Acute Ischemic Stroke, Increased Lipid Peroxidation and Lowered Antioxidant Defenses Are Strongly Associated with Disabilities and Final Stroke Core Volume

D. Barbosa, Michael Maes, F. F. Brinholi, 2023, Antioxidants.

Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis

M. Maes, A. Gadelha, C. Noto, 2015, Schizophrenia Research.